ArticleFrontiers in cardiovascular medicine2025
Computational hemodynamic assessment of axillary and femoral artery perfusion for extracorporeal left ventricular assist device.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Traditionally, the arterial blood perfusion tube for an extracorporeal left ventricular assist device (LVAD) is placed in the femoral artery, which limits patients' mobility and increases the possibility of lower limb ischemia. We have also developed a new approach for percutaneous placement using the right jugular vein and axillary artery. However, there hasn't been a direct hemodynamic comparison between axillary and femoral perfusion. Therefore, this study estimated the hemodynamic differences between axillary artery and traditional femoral artery perfusion for LVAD. Methods: Five patients underwent LVAD implantation through the right axillary artery and jugular vein approach at Wuhan Union Hospital. Based on one of their computed tomographic angiography (CTA) data, we established a computational fluid dynamics model. Key hemodynamic parameters, including time-averaged wall shear stress (TAWSS) and oscillatory shear index (OSI), were estimated to be compared. Results: The axillary perfusion improved perfusion to critical arteries and maintained more stable blood flow distribution, regardless of whether the LVAD supplied 40% or 60% of the total cardiac output. Femoral perfusion caused a substantial reduction in TAWSS and an increase in OSI, suggesting greater blood flow disturbances. In contrast, axillary perfusion maintained TAWSS values closer to normal and exhibited lower OSI, particularly in the thoracic and upper abdominal aorta. Conclusions: The axillary approach may offer superior hemodynamic performance compared with the conventional femoral approach for percutaneous LVAD, including improved perfusion of abdominal aortic branches and steadier blood flow changes. The jugular-axillary approach could be a promising procedure for future percutaneous LVAD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.